Further studies demonstrated that some of these compounds significantly inhibit tumor growth, mainly via immune modulations including the reduction of TI-Tregs and the induction of CD8+ T cells (Application number: PCT/US2021/048007). This evidence concerns the gene CD8A and neoplasm.